Indore Online Journal

Intra-Uterine Contraceptive Devices Market Poised To Reach At CAGR Of 3.5% By 2024

 Breaking News
  • No posts where found

Intra-Uterine Contraceptive Devices Market Poised To Reach At CAGR Of 3.5% By 2024

July 04
17:40 2017
The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
Data Bridge Market Research Added new industry report “Intra-Uterine Contraceptive Devices Market Poised To Reach At CAGR Of 3.5% By 2024”.

Global Intra-Uterine Contraceptive Devices Market, By Product Type (Hormonal IUCD, Copper IUCD), By End-User (Hospitals, Gynecology Clinics, Community Healthcare), By Geography (North America, Europe, Asia-Pacific, South America, Rest of the World) –Industry Trends and Forecast to 2024

The market of Global Intra-Uterine Contraceptive Devices Market is expected to reach USD 4,851.2 million by 2024 from USD 3,684.1 million in 2016, at a CAGR of 3.5% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Request for Sample Report Visit @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-intra-uterine-contraceptive-devices-market-industry-trends-forecast-2024

The major factors driving the market for Intra-Uterine Contraceptive Devices (IUCD), such as growing awareness of contraceptive, increased rate of unplanned pregnancies, rising number of initiatives undertaken by the private firms, technological advancements and favourable insurance for IUCD’s.

The Global Intra-Uterine Contraceptive Devices Market is segmented on the basis of product type, end user, and geography.

The global intra-uterine contraceptive devices market is segmented into 2 product types, namely copper IUCD and hormonal IUCD.

On the basis of end users the market is segmented into hospitals, gynaecology clinics, and community healthcare. In 2017, the hospital segment is expected to dominate the market and is expected to continue this trend till 2024.

Some of the major factors driving the market for Intra-Uterine Contraceptive Devices (IUCD), such as growing awareness of contraceptive, increased rate of unplanned pregnancies, rising number of initiatives undertaken by the private firms, technological advancements and favourable insurance for IUCD’s.

  • The growing rate of unintended pregnancies has aided the increase in the adoption of contraceptive methods which is expected to drive the growth of the IUCD market.
  • The rising number of initiatives to promote the use of intrauterine contraceptive devices acts as a significant driver for this market.
  • Growing awareness of contraceptive one of the factors contributing to the growth of the market in Europe.

Based on geography the global intra-uterine contraceptive devices market is segmented into:

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Rest of the World

Inquiry before Buying Visit @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-intra-uterine-contraceptive-devices-market-industry-trends-forecast-2024

Some of the major Companies operating in this market are:

  • Bayer AG
  • Teva Pharmaceuticals Industries Ltd.
  • Mona Lisa N.V.
  • DKT International
  • Egemen International
  • Melbea AG
  • Ocon Medical Ltd.
  • Pregna International Limited
  • Medical Engineering Corporation SA
  • SMB Corporation
  • Meril Life Sciences Pvt. Ltd.
  • Medu Scientific Ltd
  • China RH Contraceptives Co., Ltd
  • Sanghai Jolly Medical Education Co., Ltd
  • Bernstein Leibhard LLP
  • ZheijangDaji Medical Instruments, Ltd.
  • Nimble International
  • AME Line
  • Technico
  • Cepeo
  • Contraceptivos
  • InjeflexInd And Com Ltd
  • Bersil
  • Amed

Read more about the Global Intra-Uterine Contraceptive Devices Market visit @ http://databridgemarketresearch.com/global-intra-uterine-contraceptive-devices-market-growing-significant-rate-forecast-period-2017-2024/

Table of Content:

1. INTRODUCTION

       1.1. OVERVIEW OF THE INTRA-UTERINE CONTRACEPTIVE DEVICES (IUCD) MARKET

       1.2. MARKET SEGMENTATION & COVERAGE

       1.3. LIMITATION

       1.4. MARKETS COVERED

2. RESEARCH METHODOLOGY

       2.1. KEY TAKEAWAYS

       2.2. ARRIVING AT THE INTRA-UTERINE CONTRACEPTIVE DEVICES (IUCD) MARKET SIZE

                2.2.1. MARKET CRACKDOWN APPROACH

                2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS

                2.2.3. DATA TRIANGULATION

                2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES

                2.2.5. KEY DATA POINTS FROM SECONDARY SOURCES

                2.2.6. PORTER’S FIVE FORCES MATRIX

       2.3. GLOBAL INTRA-UTERINE CONTRACEPTIVE DEVICESMARKET: RESEARCH SNAPSHOT

       2.4. ASSUMPTIONS

3. MARKET OVERVIEW

       3.1. DRIVERS

                3.2.1. INCREASED RATE OF UNPLANNED PREGNANCIES

                3.2.2. RISING NUMBER OF INITIATIVES UNDERTAKEN BY THE PRIVATE FIRMS

                3.2.3. FAVOURABLE INSURANCE FOR IUCD’S

                3.2.4. GROWING AWARENESS OF CONTRACEPTIVE

                3.2.5. GROWING FUNDS AND GRANTS FOR IUCD PRODUCTS

                3.2.6. TECHNOLOGICAL ADVANCEMENTS

       3.2. RESTRAINTS

                3.2.1. HIGH COST OF TREATMENT

                3.2.2. THREAT OF CAUSING PELVIC INFLAMMOTORY DISEASE (PID)

                3.2.3. THREAT CAUSING EPICTAPIC PREGNANCY

                3.2.4. CHANGES IN GOVERNMENT REGULATIONS

4. EXECUTIVE SUMMARY

5. PREMIUM INSIGHTS

6. GLOBAL INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET, BY PRODUCT TYPE

       6.1. OVERVIEW

       6.2. HORMONAL IUCD (2013 – 2024)

                6.2.1. MARKET VALUE (USD MILLION)

                6.2.2. MARKET VOLUME (UNITS SOLD)

       6.3. COPPER IUCD (2013 – 2024)

                6.3.1. MARKET VALUE (USD MILLION)

                6.3.2. MARKET VOLUME (UNITS SOLD)

7. GLOBAL INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET, BY GEOGRAPHY

       7.1. COUNTRYWISE INTRA-UTERINE CONTRACEPTIVE DEVICES MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)

                7.1.1. NORTH AMERICA

                          7.1.1.1.      U.S.

                          7.1.1.2.      CANADA

                          7.1.1.3.      MEXICO

                7.1.2. EUROPE

                           7.1.2.1.      GERMANY

                           7.1.2.2.      FRANCE

                           7.1.2.3.      U.K.

                           7.1.2.4.      ITALY

                           7.1.2.5.      SPAIN

                           7.1.2.6.      RUSSIA

                           7.1.2.7.      TURKEY

                           7.1.2.8.      BELGIUM

                           7.1.2.9.      NETHERLANDS

                          7.1.2.10.    SWITZERLAND

                           7.1.2.11.    REST OF EUROPE

                7.1.3. ASIA-PACIFIC (APAC)

                          7.1.3.1.      JAPAN

                           7.1.3.2.      CHINA

                           7.1.3.3.      SOUTH KOREA

                           7.1.3.4.      INDIA

                           7.1.3.5.      AUSTRALIA

                           7.1.3.6.      SINGAPORE

                           7.1.3.7.      THAILAND

                           7.1.3.8.      MALAYSIA

                           7.1.3.9.      INDONESIA

                           7.1.3.10.      PHILIPPINES

                           7.1.3.11.      REST OF APAC

                7.1.4. LATIN AMERICA

                           7.1.4.1.     BRAZIL

                           7.1.4.2.     COLOMBIA

                           7.1.4.3.     ARGENTINA

                           7.1.4.4.     CHILE

                           7.1.4.5.     ECUADOR

                           7.1.4.6.     URUGUAY

                           7.1.4.7.     PARAGUAY

                           7.1.4.8.     PERU

                           7.1.4.9.     BOLIVIA

                           7.1.4.10.   REST OF LATIN AMERICA

                7.1.5. MIDDLE EAST AND AFRICA

                           7.1.5.1.     EGYPT

                           7.1.5.2.     SAUDI ARABIA

                           7.1.5.3.     REST OF SOUTH AMERICA

       7.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

8. GLOBAL INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET: COMPETITIVE LANDSCAPE

       8.1. GLOBAL IUCD MARKET: COMPANY SHARE ANALYSIS

       8.2. U.S.IUCD MARKET: COMPANY SHARE ANALYSIS

       8.3. EUROPE IUCD MARKET: COMPANY SHARE ANALYSIS

       8.4. APAC IUCD MARKET: COMPANY SHARE ANALYSIS

       8.5. SOUTH AMERICAIUCD MARKET: COMPANY SHARE ANALYSIS

       8.6. MIDDLE EAST AND AFRICA IUCD MARKET: COMPANY SHARE ANALYSIS

       8.7. MERGERS & ACQUISITIONS

       8.8. NEW PRODUCT DEVELOPMENT & APPROVALS

       8.9. EXPANSIONS

       8.10. REGULATORY CHANGES

       8.11. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS

9. GLOBAL INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET, COMPANY PROFILES

       9.1. BAYER HEALTHCARE AG

                 9.1.1   OVERVIEW

                 9.1.2   SWOT ANALYSIS

                 9.1.3   PRODUCT PORTFOLIO

                 9.1.4   REVENUE ANALYSIS

                 9.1.5   ANALYSTS VIEW

       9.2. DKT INTERNATIONAL

                 9.2.1   OVERVIEW

                 9.2.2   SWOT ANALYSIS

                 9.2.3   PRODUCT PORTFOLIO

                 9.2.4   REVENUE ANALYSIS

                 9.2.5   ANALYSTS VIEW

       9.3. TEVA PHARMACEUTICALS INDUSTRIES, LTD

                9.3.1   OVERVIEW

                9.3.2   SWOT ANALYSIS

                9.3.3   PRODUCT PORTFOLIO

                9.3.4   REVENUE ANALYSIS

                9.3.5   ANALYST VIEW

       9.4. ALLERGEN, PLC

                  9.4.1   OVERVIEW

                  9.4.2   SWOT ANALYSIS

                  9.4.3   PRODUCT PORTFOLIO

                  9.4.4   REVENUE ANALYSIS

                  9.4.5   ANALYSTS VIEW

       9.5. SMB CORPORATION

                9.5.1   OVERVIEW

                9.5.2   SWOT ANALYSIS

                9.5.3   PRODUCT PORTFOLIO

                9.5.4   REVENUE ANALYSIS

                9.5.5   ANALYSTS VIEW

       9.6. ACTAVIS PLC.

                 9.6.1   OVERVIEW

                 9.6.2   SWOT ANALYSIS

                 9.6.3   PRODUCT PORTFOLIO

                 9.6.4   REVENUE ANALYSIS

                 9.6.5   ANALYSTS VIEW

       9.7 OCON MEDICAL LTD.

                        9.7.1   OVERVIEW

                        9.7.2   SWOT ANALYSIS

                        9.7.3   PRODUCT PORTFOLIO

                        9.7.4   REVENUE ANALYSIS

                        9.7.5   ANALYSTS VIEW

       9.8   MONALISA NV

                9.8.1   OVERVIEW

                9.8.2   SWOT ANALYSIS

                9.8.3   PRODUCT PORTFOLIO

                9.8.4   REVENUE ANALYSIS

                9.8.5   ANALYSTS VIEW

       9.9   MEDISAFE DISTRIBUTION, INC.

                9.9.1   OVERVIEW

                9.9.2   SWOT ANALYSIS

                9.9.3   PRODUCT PORTFOLIO

                9.9.4   REVENUE ANALYSIS

                9.9.5   ANALYSTS VIEW

      9.10 MERIL LIFE SCIENCES PVT. LTD.

                9.10.1   OVERVIEW

                9.10.2   SWOT ANALYSIS

                9.10.3   PRODUCT PORTFOLIO

                9.10.4   REVENUE ANALYSIS

                9.10.5   ANALYSTS VIEW

Browse Full Report Visit @ http://databridgemarketresearch.com/reports/medical-devices/global-intra-uterine-contraceptive-devices-market-industry-trends-forecast-2024/

Related Report

Europe Injectable Drug Delivery Market – Industry Trends and Forecast to 2024

Europe Injectable Drug Delivery Market By Type (Devices (Conventional Injection Devices, Self Injection Devices),  Formulations (Conventional Drug Delivery, Noble Drug Delivery, Long Acting Injection Formulations), By Applications (Autoimmune Diseases, Hormonal Disorders, Orphan Diseases, Oncology, Others), By Usage Pattern (Curative Care, Immunizations, Other Usage Patterns), By Mode of Administration (Skin, Circulatory, Organs, Central Nervous System), By End User (Hospitals, Clinics, Home Care Settings, Research Laboratories, Pharma & Biotech Companies), By Country (Germany, France, U.K., Belgium, Switzerland, Italy, Spain, Russia, Turkey, Netherland and rest of Europe) – Industry Trends and Forecast to 2024

Report Access: http://databridgemarketresearch.com/reports/medical-devices/drug-delivery-devices/europe-injectable-drug-delivery-market/

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Ankit Singh

Data Bridge Market Research

Tel: +1-888-387-2818

Email: [email protected]

Investor: [email protected]

Visit Blog: http://databridgemarketresearch.com/blog/  

Follow us on LinkedIn: https://www.linkedin.com/company/data-bridge-market-research

Media Contact
Company Name: Data Bridge Market Research Private Limited
Contact Person: Ankit Singh
Email: Send Email
Phone: +1-888-387-2818
Address:Office Number 317, Amanora Chambers, Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: http://databridgemarketresearch.com/reports/medical-devices/global-intra-uterine-contraceptive-devices-market-industry-trends-forecast-2024/

Related Articles